Clinical, muscle pathological, and genetic features of Japanese facioscapulohumeral muscular dystrophy 2 (FSHD2) patients with SMCHD1 mutations
- 1 April 2016
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 26 (4-5) , 300-308
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (H25-Shinkei Kin-Ippan-004, H26-Itaku (Nan)-Ippan-081)
- JSPS KAKENHI (24659437)
- National Center of Neurology and Psychiatry (26-8, 26-7, 25-5)
This publication has 28 references indexed in Scilit:
- Population-based incidence and prevalence of facioscapulohumeral dystrophyNeurology, 2014
- Genetic and Epigenetic Characteristics of FSHD-Associated 4q and 10q D4Z4 that are Distinct from Non-4q/10q D4Z4 HomologsHuman Mutation, 2014
- A Long ncRNA Links Copy Number Variation to a Polycomb/Trithorax Epigenetic Switch in FSHD Muscular DystrophyCell, 2012
- DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53‐dependent myopathy in vivoAnnals of Neurology, 2010
- A Unifying Genetic Model for Facioscapulohumeral Muscular DystrophyScience, 2010
- Specific Loss of Histone H3 Lysine 9 Trimethylation and HP1γ/Cohesin Binding at D4Z4 Repeats Is Associated with Facioscapulohumeral Dystrophy (FSHD)PLOS Genetics, 2009
- The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic proteinNeuromuscular Disorders, 2007
- Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophyNeuromuscular Disorders, 2006
- Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophyNature Genetics, 2003
- Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomereNature Genetics, 2002